PT Bundamedik Tbk (BMHS) Fair Value & Analysis
Healthcare · ID · Market cap 1.5T IDR
Fair value as of: Jun 24, 2026
Analysis
PT Bundamedik Tbk (BMHS) currently trades at 181.00 IDR, while our model-based Fair Value estimate is 112.70 IDR — implying the stock looks roughly 37.7% overvalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, and dental clinic services management consulting businesses. It also provides fertility clinic, and oncology; emergency services; laboratory, radiology, and IVF services; and genomics and clinical pathology laboratory, and corporate health services. In addition, the company operates a BMHS nurse center, bunda neuro centre, bunda heart centre, bunda urology centre, digital substraction angiography, RSM oncology, and advanced robotic minimal invasive surgery. PT Bundamedik Tbk was founded in 1961 and is based in Jakarta Pusat, Indonesia. PT Bundamedik Tbk is a subsidiary of PT Bunda Investama Indonesia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is PT Bundamedik Tbk (BMHS) undervalued?
What is the fair value of BMHS?
What is the quality score of BMHS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.